Michael Brilhante

466 total citations
12 papers, 286 citations indexed

About

Michael Brilhante is a scholar working on Molecular Medicine, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, Michael Brilhante has authored 12 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 5 papers in Clinical Biochemistry and 3 papers in Infectious Diseases. Recurrent topics in Michael Brilhante's work include Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Bacteriophages and microbial interactions (3 papers). Michael Brilhante is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Bacteriophages and microbial interactions (3 papers). Michael Brilhante collaborates with scholars based in Switzerland, Portugal and Cuba. Michael Brilhante's co-authors include Vincent Perreten, Simone Schüller, Stefanie Gobeli Brawand, Andrea Endimiani, Barbara Willi, Valentina Donà, Stefan P. Kuster, Hélène Rohrbach, Alexandra Collaud and Sandra Quinteira and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Eurosurveillance.

In The Last Decade

Michael Brilhante

12 papers receiving 283 citations

Peers

Countries citing papers authored by Michael Brilhante

Since Specialization

Citations

This map shows the geographic impact of Michael Brilhante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Brilhante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Brilhante more than expected).

Fields of papers citing papers by Michael Brilhante

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Brilhante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Brilhante. The network helps show where Michael Brilhante may publish in the future.

Co-authorship network of co-authors of Michael Brilhante

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Brilhante. A scholar is included among the top collaborators of Michael Brilhante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Brilhante. Michael Brilhante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Duration of carriage of multidrug-resistant bacteria in dogs and cats in veterinary care and co-carriage with their owners 2021 ·One Health ·(unknown), (unknown), (unknown), Michael Brilhante, Edgar I. Campos-Madueno, (unknown), Stefan P. Kuster, Stefanie Gobeli Brawand, Barbara Willi, Andrea Endimiani, Vincent Perreten, Simone Schüller	19
2	Characterization of Third-Generation Cephalosporin-Resistant Escherichia coli Isolated from Pigs in Cuba Using Next-Generation Sequencing 2021 ·Microbial Drug Resistance ·(unknown), Michael Brilhante, (unknown), (unknown), (unknown), Vincent Perreten	5
3	Acquisition and carriage of multidrug-resistant organisms in dogs and cats presented to small animal practices and clinics in Switzerland 2021 ·Journal of Veterinary Internal Medicine ·(unknown), (unknown), (unknown), Michael Brilhante, (unknown), Stefan P. Kuster, Stefanie Gobeli Brawand, Gertraud Schüpbach‐Regula, Barbara Willi, Andrea Endimiani, Vincent Perreten, Simone Schüller	24
4	Two high-risk clones of carbapenemase-producing Klebsiella pneumoniae that cause infections in pets and are present in the environment of a veterinary referral hospital 2021 ·Journal of Antimicrobial Chemotherapy ·Michael Brilhante, Stefanie Gobeli Brawand, Andrea Endimiani, Hélène Rohrbach, Sonja Kittl, Barbara Willi, Simone Schüller, Vincent Perreten	21
5	OXA-181-Producing Extraintestinal Pathogenic Escherichia coli Sequence Type 410 Isolated from a Dog in Portugal 2020 ·Antimicrobial Agents and Chemotherapy ·Michael Brilhante, Juliana Menezes, Adriana Belas, Claudia Feudi, Štefan Schwarz, Constança Pomba, Vincent Perreten	27
6	Poor infection prevention and control standards are associated with environmental contamination with carbapenemase-producing Enterobacterales and other multidrug-resistant bacteria in Swiss companion animal clinics 2020 ·Antimicrobial Resistance and Infection Control ·(unknown), Stefan P. Kuster, (unknown), (unknown), Michael Brilhante, Hélène Rohrbach, Odette J. Bernasconi, (unknown), Edgar I. Campos-Madueno, Stefanie Gobeli Brawand, Simone Schüller, Andrea Endimiani, Vincent Perreten, Barbara Willi	42
7	Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018 2019 ·Eurosurveillance ·(unknown), Michael Brilhante, (unknown), (unknown), Alexandra Collaud, Stefanie Gobeli Brawand, Barbara Willi, Andrea Endimiani, Simone Schüller, Vincent Perreten	60
8	A Novel Trimethoprim Resistance Gene, dfrA36 , Characterized from Escherichia coli from Calves 2019 ·mSphere ·(unknown), Michael Brilhante, (unknown), (unknown), Mireille Meylan, Vincent Perreten	13
9	PFM-Like Enzymes Are a Novel Family of Subclass B2 Metallo-β-Lactamases from Pseudomonas synxantha Belonging to the Pseudomonas fluorescens Complex 2019 ·Antimicrobial Agents and Chemotherapy ·Laurent Poirel, Mattia Palmieri, Michael Brilhante, Amandine Masseron, Vincent Perreten, Patrice Nordmann	15
10	Complete Circular Genome Sequence of a Multidrug-Resistant Escherichia coli Strain from Cuba Obtained with Nanopore and Illumina Hybrid Assembly 2019 ·Microbiology Resource Announcements ·(unknown), Michael Brilhante, (unknown), Vincent Perreten	3
11	Multidrug resistance and multivirulence plasmids in enterotoxigenic and hybrid Shiga toxin-producing/enterotoxigenic Escherichia coli isolated from diarrheic pigs in Switzerland 2018 ·The Veterinary Journal ·Michael Brilhante, Vincent Perreten, Valentina Donà	25
12	Two decades of blaVIM-2-producing Pseudomonas aeruginosa dissemination: an interplay between mobile genetic elements and successful clones 2017 ·Journal of Antimicrobial Chemotherapy ·João Botelho, Filipa Grosso, Sandra Quinteira, Michael Brilhante, Helena Ramos, Luı́sa Peixe	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact